Adaptation to HLA-associated immune pressure over the course of HIV infection and in circulating HIV-1 strains

Adaptation to human leukocyte antigen (HLA)-associated immune pressure represents a major driver of human immunodeficiency virus (HIV) evolution at both the individual and population level. To date, there has been limited exploration of the impact of the initial cellular immune response in driving viral adaptation, the dynamics of these changes during infection and their effect on circulating transmitting viruses at the population level. Capturing detailed virological and immunological data from acute and early HIV infection is challenging as this commonly precedes the diagnosis of HIV infection, potentially by many years. In addition, rapid initiation of antiretroviral treatment following a diagnosis is the standard of care, and central to global efforts towards HIV elimination. Yet, acute untreated infection is the critical period in which the diversity of proviral reservoirs is first established within individuals, and associated with greater risk of onward transmissions in a population. Characterizing the viral adaptations evident in the earliest phases of infection, coinciding with the initial cellular immune responses is therefore relevant to understanding which changes are of greatest impact to HIV evolution at the population level. In this study, we utilized three separate cohorts to examine the initial CD8+ T cell immune response to HIV (cross-sectional acute infection cohort), track HIV evolution in response to CD8+ T cell-mediated immunity over time (longitudinal chronic infection cohort) and translate the impact of HLA-driven HIV evolution to the population level (cross-sectional HIV sequence data spanning 30 years). Using next generation viral sequencing and enzyme-linked immunospot interferon-gamma recall responses to peptides representing HLA class I-specific HIV T cell targets, we observed that CD8+ T cell responses can select viral adaptations prior to full antibody seroconversion. Using the longitudinal cohort, we uncover that viral adaptations have the propensity to be retained over time in a non-selective immune environment, which reflects the increasing proportion of pre-adapted HIV strains within the Western Australian population over an approximate 30-year period.

[1]  M. John,et al.  Cross-Reactivity to Mutated Viral Immune Targets Can Influence CD8+ T Cell Functionality: An Alternative Viral Adaptation Strategy , 2021, Frontiers in Immunology.

[2]  M. Massanella,et al.  Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study , 2021, The Lancet. Microbe.

[3]  F. Klein,et al.  Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody , 2020, Proceedings of the National Academy of Sciences.

[4]  Carlos P. Modenutti,et al.  Longitudinal characterization of HIV-1 pol-gene in treatment-naïve men-who-have-sex-with-men from acute to chronic infection stages , 2020, Heliyon.

[5]  J. Joy,et al.  HIV-1 variants are archived throughout infection and persist in the reservoir , 2020, PLoS pathogens.

[6]  Frederick A. Matsen IV,et al.  Dynamics of HIV DNA reservoir seeding in a cohort of superinfected Kenyan women , 2020, PLoS pathogens.

[7]  J. Joy,et al.  Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study , 2020, Retrovirology.

[8]  Joseph A Conrad,et al.  Deep sequence analysis of HIV adaptation following vertical transmission reveals the impact of immune pressure on the evolution of HIV , 2019, PLoS pathogens.

[9]  M. John,et al.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure , 2019, Current opinion in HIV and AIDS.

[10]  T. Greenough,et al.  Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth , 2019, AIDS.

[11]  F. Ceccherini‐Silberstein,et al.  Genetic divergence of HIV-1 B subtype in Italy over the years 2003–2016 and impact on CTL escape prevalence , 2018, Scientific Reports.

[12]  P. Harrigan,et al.  Extensive host immune adaptation in a concentrated North American HIV epidemic , 2018, AIDS.

[13]  C. Fraser,et al.  Evolution of HIV-1 within untreated individuals and at the population scale in Uganda , 2018, PLoS pathogens.

[14]  Galit Alter,et al.  Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) , 2018, The Lancet.

[15]  Sudhir Kumar,et al.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.

[16]  G. Gottlieb,et al.  HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. , 2018, Vaccine.

[17]  S. Mallal,et al.  HIV integration sites in latently infected cell lines: evidence of ongoing replication , 2017, Retrovirology.

[18]  Charles E. DeZiel,et al.  Impact of Pre-adapted HIV Transmission , 2016, Nature Medicine.

[19]  G. Gao,et al.  Rapid HIV-1 Disease Progression in Individuals Infected with a Virus Adapted to Its Host Population , 2016, PloS one.

[20]  M. John,et al.  Longitudinal Trends in Western Australian HIV-1 Sequence Diversity and Viral Transmission Networks and Their Influence on Clinical Parameters: 2000-2014. , 2016, AIDS research and human retroviruses.

[21]  P. Goulder,et al.  Role of HLA Adaptation in HIV Evolution , 2016, Front. Immunol..

[22]  A. Haase,et al.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.

[23]  R. Siliciano,et al.  Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations , 2015, Nature.

[24]  James Robinson,et al.  The IPD and IMGT/HLA database: allele variant databases , 2014, Nucleic Acids Res..

[25]  Angela R. McLean,et al.  Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence , 2014, Proceedings of the National Academy of Sciences.

[26]  P. Goulder,et al.  Impact of HLA Selection Pressure on HIV Fitness at a Population Level in Mexico and Barbados , 2014, Journal of Virology.

[27]  Jinyan Liu,et al.  Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys , 2014, Nature.

[28]  Jessica Prince,et al.  Selection bias at the heterosexual HIV-1 transmission bottleneck , 2013, Science.

[29]  D. Heckerman,et al.  HIV escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes , 2013, AIDS.

[30]  David Heckerman,et al.  Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 , 2012, Journal of Virology.

[31]  D. Heckerman,et al.  High-avidity, high-IFNγ-producing CD8 T-cell responses following immune selection during HIV-1 infection , 2011, Immunology and cell biology.

[32]  D. Heckerman,et al.  Translation of HLA–HIV Associations to the Cellular Level: HIV Adapts To Inflate CD8 T Cell Responses against Nef and HLA-Adapted Variant Epitopes , 2011, The Journal of Immunology.

[33]  Brigitte Autran,et al.  Escape from highly effective public CD8+ T-cell clonotypes by HIV. , 2011, Blood.

[34]  J. Kublin,et al.  Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. , 2011, The Lancet. Infectious diseases.

[35]  F. Hecht,et al.  The detection of acute HIV infection. , 2010, The Journal of infectious diseases.

[36]  D. Heckerman,et al.  Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses. , 2010, Vaccine.

[37]  D. Heckerman,et al.  Adaptive Interactions between HLA and HIV-1: Highly Divergent Selection Imposed by HLA Class I Molecules with Common Supertype Motifs , 2010, The Journal of Immunology.

[38]  Alan S. Perelson,et al.  The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.

[39]  Xiping Wei,et al.  Kinetics of Expansion of Epitope-Specific T Cell Responses during Primary HIV-1 Infection1 , 2009, The Journal of Immunology.

[40]  David Heckerman,et al.  Adaptation of HIV-1 to human leukocyte antigen class I , 2009, Nature.

[41]  Devan V Mehrotra,et al.  Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial , 2008, The Lancet.

[42]  M. Carrington,et al.  HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection , 2008, Journal of Virology.

[43]  D. Heckerman,et al.  Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.

[44]  Winston A Hide,et al.  Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.

[45]  James I Mullins,et al.  HIV-1 Group M Conserved Elements Vaccine , 2007, PLoS pathogens.

[46]  P. Klenerman,et al.  AIDS/HIV: Finding Footprints Among the Trees , 2007, Science.

[47]  D. Nixon,et al.  Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape , 2007, PloS one.

[48]  B. Schmidt,et al.  Dual Selection Pressure by Drugs and HLA Class I-Restricted Immune Responses on Human Immunodeficiency Virus Type 1 Protease , 2007, Journal of Virology.

[49]  Bin Li,et al.  Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution , 2006, Journal of Virology.

[50]  Tulio de Oliveira,et al.  An automated genotyping system for analysis of HIV-1 and other microbial sequences , 2005, Bioinform..

[51]  W. Paxton,et al.  Broad Cross-Clade T-Cell Responses to Gag in Individuals Infected with Human Immunodeficiency Virus Type 1 Non-B Clades (A to G): Importance of HLA Anchor Residue Conservation , 2005, Journal of Virology.

[52]  M. Mulligan,et al.  CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides , 2005, AIDS.

[53]  H. Kishino,et al.  Dating of the human-ape splitting by a molecular clock of mitochondrial DNA , 2005, Journal of Molecular Evolution.

[54]  Bette Korber,et al.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.

[55]  Bette Korber,et al.  HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity , 2004, AIDS.

[56]  M. Altfeld,et al.  Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection , 2004, The Journal of experimental medicine.

[57]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[58]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[59]  D. Montefiori,et al.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.

[60]  M A Nowak,et al.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R Brookmeyer,et al.  Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.

[62]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[63]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.

[64]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[65]  M. Nei,et al.  Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. , 1993, Molecular biology and evolution.

[66]  Charles R. M. Bangham,et al.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.